United States Thrombin Inhibitors Market Report 2016

Publisher Name :
Date: 05-Oct-2016
No. of pages: 117
Inquire Before Buying

Notes:

Sales, means the sales volume of Thrombin Inhibitors

Revenue, means the sales value of Thrombin Inhibitors

This report studies sales (consumption) of Thrombin Inhibitors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer AG

- Pfizer Inc

- Merck

- Sanofi

- Abbott Laboratories

- Johnson & Johnson

- Armetheon Inc

- Microbix Biosystems Inc

- Biovascular Inc

- Baxter International

- Astrazeneca

- Genentech

- Boehringer Ingelheim Gmbh

- Bristol-Myers Squibb CO

- CSL Behring

- ELI LILLY

- Emisphere Technologies

- Sun Pharmaceuticals

- Shire Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Argatroban

- Angiomax

- Iprivask

- Pradaxa

- Activase

- Retavase

- TNKase

- ATryn

Split by applications, this report focuses on sales, market share and growth rate of Thrombin Inhibitors in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Thrombin Inhibitors Market Report 2016

Table of Contents
United States Thrombin Inhibitors Market Report 2016
1 Thrombin Inhibitors Overview
1.1 Product Overview and Scope of Thrombin Inhibitors
1.2 Classification of Thrombin Inhibitors
1.2.1 Argatroban
1.2.2 Angiomax
1.2.3 Iprivask
1.2.4 Pradaxa
1.2.5 Activase
1.2.6 Retavase
1.2.7 TNKase
1.2.8 ATryn
1.3 Application of Thrombin Inhibitors
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Thrombin Inhibitors (2011-2021)
1.4.1 United States Thrombin Inhibitors Sales and Growth Rate (2011-2021)
1.4.2 United States Thrombin Inhibitors Revenue and Growth Rate (2011-2021)
2 United States Thrombin Inhibitors Competition by Manufacturers
2.1 United States Thrombin Inhibitors Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Thrombin Inhibitors Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Thrombin Inhibitors Average Price by Manufactures (2015 and 2016)
2.4 Thrombin Inhibitors Market Competitive Situation and Trends
2.4.1 Thrombin Inhibitors Market Concentration Rate
2.4.2 Thrombin Inhibitors Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Thrombin Inhibitors Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Thrombin Inhibitors Sales and Market Share by Type (2011-2016)
3.2 United States Thrombin Inhibitors Revenue and Market Share by Type (2011-2016)
3.3 United States Thrombin Inhibitors Price by Type (2011-2016)
3.4 United States Thrombin Inhibitors Sales Growth Rate by Type (2011-2016)
4 United States Thrombin Inhibitors Sales (Volume) by Application (2011-2016)
4.1 United States Thrombin Inhibitors Sales and Market Share by Application (2011-2016)
4.2 United States Thrombin Inhibitors Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Thrombin Inhibitors Manufacturers Profiles/Analysis
5.1 Bayer AG
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Thrombin Inhibitors Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer AG Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Pfizer Inc
5.2.2 Thrombin Inhibitors Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Pfizer Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Merck
5.3.2 Thrombin Inhibitors Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Merck Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Sanofi
5.4.2 Thrombin Inhibitors Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Sanofi Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Abbott Laboratories
5.5.2 Thrombin Inhibitors Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Abbott Laboratories Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Johnson & Johnson
5.6.2 Thrombin Inhibitors Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Johnson & Johnson Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Armetheon Inc
5.7.2 Thrombin Inhibitors Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Armetheon Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Microbix Biosystems Inc
5.8.2 Thrombin Inhibitors Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Microbix Biosystems Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Biovascular Inc
5.9.2 Thrombin Inhibitors Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Biovascular Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Baxter International
5.10.2 Thrombin Inhibitors Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Baxter International Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Astrazeneca
5.12 Genentech
5.13 Boehringer Ingelheim Gmbh
5.14 Bristol-Myers Squibb CO
5.15 CSL Behring
5.16 ELI LILLY
5.17 Emisphere Technologies
5.18 Sun Pharmaceuticals
5.19 Shire Pharmaceuticals
6 Thrombin Inhibitors Manufacturing Cost Analysis
6.1 Thrombin Inhibitors Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Thrombin Inhibitors
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Thrombin Inhibitors Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Thrombin Inhibitors Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Thrombin Inhibitors Market Forecast (2016-2021)
10.1 United States Thrombin Inhibitors Sales, Revenue Forecast (2016-2021)
10.2 United States Thrombin Inhibitors Sales Forecast by Type (2016-2021)
10.3 United States Thrombin Inhibitors Sales Forecast by Application (2016-2021)
10.4 Thrombin Inhibitors Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Thrombin Inhibitors
Table Classification of Thrombin Inhibitors
Figure United States Sales Market Share of Thrombin Inhibitors by Type in 2015
Figure Argatroban Picture
Figure Angiomax Picture
Figure Iprivask Picture
Figure Pradaxa Picture
Figure Activase Picture
Figure Retavase Picture
Figure TNKase Picture
Figure ATryn Picture
Table Application of Thrombin Inhibitors
Figure United States Sales Market Share of Thrombin Inhibitors by Application in 2015
Figure United States Thrombin Inhibitors Sales and Growth Rate (2011-2021)
Figure United States Thrombin Inhibitors Revenue and Growth Rate (2011-2021)
Table United States Thrombin Inhibitors Sales of Key Manufacturers (2015 and 2016)
Table United States Thrombin Inhibitors Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Thrombin Inhibitors Sales Share by Manufacturers
Figure 2016 Thrombin Inhibitors Sales Share by Manufacturers
Table United States Thrombin Inhibitors Revenue by Manufacturers (2015 and 2016)
Table United States Thrombin Inhibitors Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Thrombin Inhibitors Revenue Share by Manufacturers
Table 2016 United States Thrombin Inhibitors Revenue Share by Manufacturers
Table United States Market Thrombin Inhibitors Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Thrombin Inhibitors Average Price of Key Manufacturers in 2015
Figure Thrombin Inhibitors Market Share of Top 3 Manufacturers
Figure Thrombin Inhibitors Market Share of Top 5 Manufacturers
Table United States Thrombin Inhibitors Sales by Type (2011-2016)
Table United States Thrombin Inhibitors Sales Share by Type (2011-2016)
Figure United States Thrombin Inhibitors Sales Market Share by Type in 2015
Table United States Thrombin Inhibitors Revenue and Market Share by Type (2011-2016)
Table United States Thrombin Inhibitors Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Thrombin Inhibitors by Type (2011-2016)
Table United States Thrombin Inhibitors Price by Type (2011-2016)
Figure United States Thrombin Inhibitors Sales Growth Rate by Type (2011-2016)
Table United States Thrombin Inhibitors Sales by Application (2011-2016)
Table United States Thrombin Inhibitors Sales Market Share by Application (2011-2016)
Figure United States Thrombin Inhibitors Sales Market Share by Application in 2015
Table United States Thrombin Inhibitors Sales Growth Rate by Application (2011-2016)
Figure United States Thrombin Inhibitors Sales Growth Rate by Application (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Thrombin Inhibitors Sales Market Share (2011-2016)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc Thrombin Inhibitors Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Thrombin Inhibitors Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Thrombin Inhibitors Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Thrombin Inhibitors Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Thrombin Inhibitors Sales Market Share (2011-2016)
Table Armetheon Inc Basic Information List
Table Armetheon Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Armetheon Inc Thrombin Inhibitors Sales Market Share (2011-2016)
Table Microbix Biosystems Inc Basic Information List
Table Microbix Biosystems Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Microbix Biosystems Inc Thrombin Inhibitors Sales Market Share (2011-2016)
Table Biovascular Inc Basic Information List
Table Biovascular Inc Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biovascular Inc Thrombin Inhibitors Sales Market Share (2011-2016)
Table Baxter International Basic Information List
Table Baxter International Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter International Thrombin Inhibitors Sales Market Share (2011-2016)
Table Astrazeneca Basic Information List
Table Astrazeneca Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astrazeneca Thrombin Inhibitors Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Thrombin Inhibitors Sales Market Share (2011-2016)
Table Boehringer Ingelheim Gmbh Basic Information List
Table Boehringer Ingelheim Gmbh Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Gmbh Thrombin Inhibitors Sales Market Share (2011-2016)
Table Bristol-Myers Squibb CO Basic Information List
Table Bristol-Myers Squibb CO Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb CO Thrombin Inhibitors Sales Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Behring Thrombin Inhibitors Sales Market Share (2011-2016)
Table ELI LILLY Basic Information List
Table ELI LILLY Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table ELI LILLY Thrombin Inhibitors Sales Market Share (2011-2016)
Table Emisphere Technologies Basic Information List
Table Emisphere Technologies Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Emisphere Technologies Thrombin Inhibitors Sales Market Share (2011-2016)
Table Sun Pharmaceuticals Basic Information List
Table Sun Pharmaceuticals Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceuticals Thrombin Inhibitors Sales Market Share (2011-2016)
Table Shire Pharmaceuticals Basic Information List
Table Shire Pharmaceuticals Thrombin Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Pharmaceuticals Thrombin Inhibitors Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thrombin Inhibitors
Figure Manufacturing Process Analysis of Thrombin Inhibitors
Figure Thrombin Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of Thrombin Inhibitors Major Manufacturers in 2015
Table Major Buyers of Thrombin Inhibitors
Table Distributors/Traders List
Figure United States Thrombin Inhibitors Production and Growth Rate Forecast (2016-2021)
Figure United States Thrombin Inhibitors Revenue and Growth Rate Forecast (2016-2021)
Table United States Thrombin Inhibitors Production Forecast by Type (2016-2021)
Table United States Thrombin Inhibitors Consumption Forecast by Application (2016-2021)
  • United States, EU, Japan, China, India and Southeast Asia Pharmacy Automation Market Size, Status and Forecast 2021
    Published: 05-Dec-2016        Price: US 3300 Onwards        Pages: 106
    Notes: Production, means the output of Pharmacy Automation Revenue, means the sales value of Pharmacy Automation This report studies the global Pharmacy Automation market, analyzes and researches the Pharmacy Automation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - BD - Baxter International - TOSHO - Takazono - Omnicell......
  • Global Interventional Oncology Device Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Interventional Oncology Device Revenue, means the sales value of Interventional Oncology Device This report studies sales (consumption) of Interventional Oncology Device in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Philips Volcano - Boston Scientific......
  • Global Intranasal Corticosteroids Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Intranasal Corticosteroids Revenue, means the sales value of Intranasal Corticosteroids This report studies sales (consumption) of Intranasal Corticosteroids in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi - Johnson & Joh......
  • Global Interventional Oncology Devices Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 117
    Notes: Sales, means the sales volume of Interventional Oncology Devices Revenue, means the sales value of Interventional Oncology Devices This report studies sales (consumption) of Interventional Oncology Devices in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Philips Volcano - Boston Scientific......
  • Global Leukotriene Receptor Antagonist Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Leukotriene Receptor Antagonist Revenue, means the sales value of Leukotriene Receptor Antagonist This report studies sales (consumption) of Leukotriene Receptor Antagonist in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi ......
  • United States Drugs for Non-small Cell Lung Cancer Market Report 2016
    Published: 01-Dec-2016        Price: US 3800 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Drugs for Non-small Cell Lung Cancer Revenue, means the sales value of Drugs for Non-small Cell Lung Cancer This report studies sales (consumption) of Drugs for Non-small Cell Lung Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bristol-Myers Squibb - GlaxoSmithKline - Menarini - Sanofi - ZIOPHARM Oncology......
  • Global Levocetirizine Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Levocetirizine Revenue, means the sales value of Levocetirizine This report studies sales (consumption) of Levocetirizine in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Sanofi - GlaxoSmithKline - ... Market Segment by Regions, this report sp......
  • Global Oral Antihistamines Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 100
    Notes: Sales, means the sales volume of Oral Antihistamines Revenue, means the sales value of Oral Antihistamines This report studies sales (consumption) of Oral Antihistamines in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi - Johnson & Johnson - ALK-Abe......
  • Global Pembrolizumab Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Pembrolizumab Revenue, means the sales value of Pembrolizumab This report studies sales (consumption) of Pembrolizumab in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Merck & Co., Inc. - Novartis AG - Onxeo SA - Sumitomo Dainippon Pharma Co.,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs